Compounds > butylscopolammonium bromide
Page last updated: 2024-09-04

butylscopolammonium bromide and Dermatitis Medicamentosa

butylscopolammonium bromide has been researched along with Dermatitis Medicamentosa in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rashid Dar, N; Raza, N1
Kanwar, AJ; Majid, A; Malhotra, YK; Singh, M1
Belhaj, MS; Bharija, SC; Kanwar, AJ; Mohammed, M1

Other Studies

3 other study(ies) available for butylscopolammonium bromide and Dermatitis Medicamentosa

ArticleYear
Drug induced linear IgA disease with unusual features: Koebner phenomenon, local insulin sensitivity and annular blister of the nipples.
    Acta dermatovenerologica Croatica : ADC, 2008, Volume: 16, Issue:4

    Topics: Adult; Anti-Infective Agents; Autoimmune Diseases; Butylscopolammonium Bromide; Drug Eruptions; Humans; Immunoglobulin A; Insulin Resistance; Male; Metronidazole; Muscarinic Antagonists; Nipples; Skin Diseases, Vesiculobullous

2008
An usual presentation of fixed drug eruption.
    Dermatologica, 1982, Volume: 164, Issue:2

    Topics: Adult; Aminopyrine; Butylscopolammonium Bromide; Dipyrone; Drug Combinations; Drug Eruptions; Humans; Male; Parasympatholytics; Scopolamine Derivatives; Tetracycline

1982
Drugs causing fixed eruptions.
    The Journal of dermatology, 1984, Volume: 11, Issue:4

    Topics: Adult; Aspirin; Butylscopolammonium Bromide; Cross Reactions; Dipyrone; Drug Eruptions; Drug Interactions; Female; Humans; Ibuprofen; Male; Oxyphenbutazone; Sulfadiazine; Tetracycline

1984